Small Stocks, Big Money™

Gorilla Technology Group (Nasdaq: GRRR) announced a $6 million share buyback, citing significant undervaluation of its stock after a sharp market cap drop from $650 million to $35 million. The company plans to repurchase 1.1 million shares within five days, supported by strong cash reserves of over $40 million. CEO Jay Chandan emphasized the buyback as a strategic move to boost shareholder value and reflect Gorilla's solid financial position, including real estate assets valued at $25 million. Unaudited H1 2024 financials are expected by September 30, 2024.

OS Therapies (NYSE American: OSTX) announced strong preclinical results for its ovarian cancer therapeutic candidate, developed using its proprietary tunable Antibody Drug Conjugate (tADC) platform. The folate receptor alpha-targeting drug conjugate (FRA-H) demonstrated significant tumor reduction in mouse models, with no observed safety issues such as bodyweight loss. This proof-of-concept success showcases the potential of OS Therapies' SiLinker™ technology to deliver multiple therapeutic agents selectively to tumors, paving the way for future preclinical and clinical candidates. The global ADC market is projected to reach $20.9 billion by 2030.

Zomedica Corp. (NYSE American: ZOM) completed renovations at its 30,000-square-foot manufacturing, distribution, and R&D center in Plymouth, Minnesota, significantly boosting its production capacity. The upgrades include an expanded cleanroom and a new automated line capable of producing up to one million TRUFORMA® cartridges annually, improving efficiency and meeting rising demand. This state-of-the-art facility will support the continued growth of the TRUFORMA diagnostic platform, which offers highly precise, point-of-care diagnostics for equine and companion animals. Zomedica remains focused on advancing its veterinary health solutions.

Global MMA icon Conor McGregor expanded his ownership in Alta Global Group (NYSE American: MMA) through a performance-based share agreement, receiving up to 700,000 performance share rights tied to share price milestones of up to $20 per share. As Alta’s global ambassador, McGregor will leverage his influence over 63 million followers and 640 million UFC fans to promote Alta’s platforms, including TrainAlta.com and Hype.co. This partnership is expected to drive significant growth for Alta, aligning McGregor’s success with the company’s expansion in the combat sports sector.